Litcius/Paper detail

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Tom P. Freeman, Chandni Hindocha, Gianluca Baio, Natacha D. C. Shaban, Emily M Thomas, Danica Astbury, Abigail M. Freeman, Rachel Lees, Sam Craft, Paul D. Morrison, Michael Bloomfield, Dominic O’Ryan, Jane Kinghorn, Celia J. A. Morgan, Ali Mofeez, Valerie H. Curran

2020The Lancet Psychiatry198 citationsDOIOpen Access PDF

Topics & Concepts

CannabidiolPlaceboCannabisMedicineDouble blindBayesian probabilityPsychiatryPsychologyAlternative medicineComputer scienceArtificial intelligencePathologyCannabis and Cannabinoid ResearchSubstance Abuse Treatment and OutcomesPsychedelics and Drug Studies